» Articles » PMID: 23504808

Vitamin D and Nonalcoholic Fatty Liver Disease (NAFLD): is It More Than Just an Association?

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2013 Mar 19
PMID 23504808
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Vitamin D is a secosteroid with known effects on calcium homeostasis that has recently been shown to have other significant functions regarding immune modulation, cell differentiation and proliferation, and the inflammatory response. As our understanding of the many functions of vitamin D has grown, the presence of vitamin D deficiency (VDD) has become more evident in Western populations. Concomitantly, nonalcoholic fatty liver disease (NAFLD) has become the most common cause of chronic liver disease. NAFLD and VDD are often found together, and while this is not unexpected, given their similar associations with obesity and sedentary lifestyle, a growing body of evidence points to a closely linked and potentially causative relationship between VDD and NAFLD. The epidemiologic association between VDD and NAFLD as well as the role of VDD in the pathogenesis of NAFLD and the available evidence on the clinical utility of vitamin D replacement in NAFLD populations are discussed.

Citing Articles

Potential predictive role of Non-HDL to HDL Cholesterol Ratio (NHHR) in MASLD: focus on obese and type 2 diabetic populations.

Ma X, Guo Y, Jiang S, Li K, Zheng Y, Guo X BMC Gastroenterol. 2025; 25(1):79.

PMID: 39948471 PMC: 11827471. DOI: 10.1186/s12876-025-03659-8.


The relationship between non-HDL cholesterol to HDL cholesterol ratio (NHHR) and anemia: A cross-sectional study of NHANES, 2009 to 2016.

Cao N, Wang J, Zhu J, Jiao X, An F, Zhai Z Medicine (Baltimore). 2024; 103(50):e40976.

PMID: 39686411 PMC: 11651433. DOI: 10.1097/MD.0000000000040976.


Efficacy of Adding Sitagliptin to Ongoing Metformin on Metabolic Profile, Triglyceride-Glucose Index, Vitamin D3, and Liver Tests in Patients Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial.

Yaribeygi H, Ramezani M, Katsiki N, Mirmohammadkhani M, Tabaei N Curr Ther Res Clin Exp. 2024; 101:100764.

PMID: 39582742 PMC: 11584711. DOI: 10.1016/j.curtheres.2024.100764.


Association of non-high-density lipoprotein cholesterol-to-high-density lipoprotein cholesterol ratio (NHHR) with gout prevalence: a cross-sectional study.

Guo X, Chu H, Xu H, Wang S, He J, Wang Y Front Nutr. 2024; 11:1480689.

PMID: 39512523 PMC: 11541233. DOI: 10.3389/fnut.2024.1480689.


Bioactive metabolites: A clue to the link between MASLD and CKD?.

Chen W, Zhang J, Chen L, Byrne C, Targher G, Luo L Clin Mol Hepatol. 2024; 31(1):56-73.

PMID: 39428978 PMC: 11791555. DOI: 10.3350/cmh.2024.0782.